Lexaria Bioscience raises about $5.9 million via warrant exercise
Lexaria Bioscience secured about $5.9 million gross proceeds after holders exercised 453,969 existing warrants at $12.92 per share under inducement offer letters. The company will issue new unregistered Series A and Series B warrants.